• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Market Analysis Latest ASX News

Althea Share Price Surge Continues | ASX:AGH

Like 0

By Lachlann Tierney, Monday, 14 September 2020

At the time of writing the share price of Althea Group Holdings Ltd [ASX:AGH] is up nearly 10%, to trade at 63.5 cents. There are two things working in favour of the AGH share price at the moment...

At the time of writing the share price of Althea Group Holdings Ltd [ASX:AGH] is up nearly 10%, to trade at 63.5 cents.

Since the March market lows, the AGH share price has since gone on a significant run over the last two weeks:

Althea share price

Source: tradingview.com

There are two things working in favour of the AGH share price at the moment.

Canadian licence boosts AGH share price

In today’s announcement, their Peak Processing Solutions subsidiary got the go ahead from Health Canada — so their operations can immediately commence.

In particular, Peak is focused on infused beverages.

So, a significant boon for Althea in a massive market.

Secondly, another recent announcement from the company welcomed a change of TGA policy with regards to CBD products in Australia.

Meaning that in consultation with a pharmacist, Australian patients will be able to get CBD without a prescription.

It’s an interim decision, but it I think it will materially impact Althea’s revenue in the coming quarters, as it is very focused on the fledgling Australian market.

Outlook for AGH share price

Althea went on an immense run in mid-2019 but was savaged by a broader trend in cannabis stocks globally.

With limited revenues many of these companies sold off despite the significant long-term potential.

It’s quite possible that March was the bottom for the AGH share price and future positive news flow could drive AGH higher.

It will be interesting to see the next quarterly now that Peak is up and running.

Regards,

Lachlann Tierney,
For Money Morning

PS: Four Well-Positioned Small-Cap Stocks: These innovative Aussie companies are well placed to capitalise on post-lockdown megatrends. Click here to learn more.

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Comments

Subscribe
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments
Lachlann Tierney
Lachlann ‘Lachy’ Tierney is passionate about uncovering hidden opportunities in the microcap sector. With four years of experience as a senior equities analyst at one of Australia’s leading microcap firms, he has built a reputation for rigorous research, deep-dive due diligence, and accessible investor communications. Over this time, he has vetted seed, pre-IPO and ASX-listed companies across sectors, conducted onsite visits, and built strong relationships across the microcap space. Lachy is nearing completion of a PhD in economics at RMIT University, where his research focuses on blockchain governance and voting systems. His work was housed within the Blockchain Innovation Hub at RMIT, a leading research centre for crypto-economics and blockchain research. He holds a Master’s degree from the London School of Economics and an Honours BA in Philosophy and Politics from the University of Melbourne. Born in New York and raised in California, Lachy grew up a few blocks from biotech giant Amgen and counts among his peers various characters in the overlapping worlds of venture capital, technology and crypto. When he’s not researching microcaps, he’s most likely sweating it out in a sauna or dunking himself in cold Tasmanian water.

Lachlann’s Premium Subscriptions

Publication logo
Australian Small-Cap Investigator
Publication logo
Fat Tail Microcaps
Publication logo
James Altucher’s Early-Stage Crypto Investor Australia

Latest Articles

  • China’s playbook narrows, and it likely means more commodities
    By Lachlann Tierney

    China is in a tricky spot with Venezuela and Iran off the board. It will likely have to double down on metals, as it has done previously.

  • Trump is targeting China, Cuba and Russia via the shadow oil market
    By Jim Rickards

    Iran and Venezuela have a lot of oil. But who they sell it to at a discount is what got the US President’s attention. His real target is Russia, Cuba and China.

  • Bottoms up in Victoria, Market Chaos and The One Thing in Your Control
    By Lachlann Tierney

    A day of rest in Victoria, chaos in the Middle East, and the hard work that makes it all tick. Tomorrow: China’s economy.

Primary Sidebar

Latest Articles

  • China’s playbook narrows, and it likely means more commodities
  • Trump is targeting China, Cuba and Russia via the shadow oil market
  • Bottoms up in Victoria, Market Chaos and The One Thing in Your Control
  • O&G Prediction Emerges
  • Making sense of the attack on Iran through the prism of Venezuela

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988